Literature DB >> 19961044

Anaesthesia for total knee arthroplasty: efficacy of single-injection or continuous lumbar plexus associated with sciatic nerve blocks--a randomized controlled study.

L Frassanito1, A Vergari, A Messina, S Pitoni, C Puglisi, A Chierichini.   

Abstract

Total knee arthroplasty (TKA) often results in marked postoperative pain. We compared in a randomized controlled study tramadol consumption, postoperative pain and patient satisfaction after primary TKA in patients who received a single injection lumbar plexus and sciatic nerve blocks or a continuous lumbar plexus and sciatic nerve blocks. Forty-four patients scheduled for unilateral total knee arthroplasty were allocated to the single shot group (group A) or to the catheter group (group B). All patients (in both groups) reported being satisfied with their anaesthetic management. Although pain scores and tramadol consumption appeared lower in the active infusion group, the differences did not reach statistical significance. This study confirms that either single injection or continuous infusion of Ropivacaine in lumbar plexus provides reliable and long-acting anaesthesia and analgesia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961044

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

Review 1.  Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs.

Authors:  Antje Barreveld; Jürgen Witte; Harkirat Chahal; Marcel E Durieux; Gary Strichartz
Journal:  Anesth Analg       Date:  2013-02-13       Impact factor: 5.108

Review 2.  Femoral nerve blocks for acute postoperative pain after knee replacement surgery.

Authors:  Ee-Yuee Chan; Marlene Fransen; David A Parker; Pryseley N Assam; Nelson Chua
Journal:  Cochrane Database Syst Rev       Date:  2014-05-13

Review 3.  Postoperative pain treatment after total knee arthroplasty: A systematic review.

Authors:  Anders Peder Højer Karlsen; Mik Wetterslev; Signe Elisa Hansen; Morten Sejer Hansen; Ole Mathiesen; Jørgen B Dahl
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.